Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Short Interest Update

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the recipient of a large increase in short interest during the month of November. As of November 30th, there was short interest totalling 17,500 shares, an increase of 21.5% from the November 15th total of 14,400 shares. Based on an average trading volume of 20,900 shares, the days-to-cover ratio is currently 0.8 days.

Reviva Pharmaceuticals Stock Down 9.7 %

RVPHW stock traded down $0.03 during trading hours on Monday, hitting $0.28. 42,059 shares of the stock were exchanged, compared to its average volume of 18,729. Reviva Pharmaceuticals has a 12 month low of $0.07 and a 12 month high of $1.62. The company has a 50-day simple moving average of $0.17 and a two-hundred day simple moving average of $0.18.

Reviva Pharmaceuticals Company Profile

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.